The UK government has announced an additional £100 million to ensure that any successful Covid-19 vaccine can be produced at scale.

The money will fund a Cell and Gene Therapy Catapult Manufacturing Innovation Centre to accelerate the mass production of a vaccine. Due to open in December 2021, the Centre will have the capacity to produce millions of doses each month.

Located in Braintree, Essex, the initiative will upgrade an existing facility to create a fully-licensed manufacturing centre.

The new centre will complement the Vaccines Manufacturing and Innovation Centre, which is currently under construction in Oxfordshire following a £93 million investment from the government.

Business Secretary Alok Sharma said: “We are taking all necessary steps to ensure we can vaccinate the public as soon as a successful Covid-19 vaccine becomes available. This new Cell and Gene Therapy Catapult Manufacturing Innovation Centre, alongside crucial investment in skills, will support our efforts to rapidly produce millions of doses of a coronavirus vaccine while ensuring the UK can respond quickly to potential future pandemics.”

Date published: July 24, 2020

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login